Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications

Platelets. 2016 Jul;27(5):393-401. doi: 10.3109/09537104.2016.1144179. Epub 2016 Mar 7.

Abstract

Beyond key functions in hemostasis and thrombosis, platelets are recognized as key players of inflammation, an underlying feature of a variety of diseases. In this regard, platelets act as a circulating source of several pro- and anti-inflammatory molecules, which are secreted from their intracellular stores upon activation. Among them, mounting evidence highlights a crucial role of sphingosine-1-phosphate (S1P), a multifunctional sphingoid mediator. S1P-induced pleiotropic effects include those crucial in inflammatory processes, such as the maintenance of the endothelial barrier integrity, and leukocyte activation and recruitment at the injured site. This review outlines the peculiar features and molecular mechanisms that allow platelets for acting as a unique factory that produces and stores S1P in large quantities. A particular emphasis is placed on the autocrine and paracrine roles of S1P derived from the "inflamed" platelets, highlighting the role of its cross-talk with endothelial and blood cells involved in inflammation, and the mechanisms of its contribution to the development and progression of inflammatory diseases. Finally, potential clinical implications of platelet-derived S1P as diagnostic tool of inflammatory severity, and as therapeutic target in inflammation are discussed.

Keywords: Inflammation; platelets; sphingosine-1-phosphate.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Autocrine Communication
  • Biological Transport
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Humans
  • Inflammation / blood
  • Inflammation / diagnosis
  • Inflammation / drug therapy
  • Inflammation / metabolism*
  • Leukocytes / metabolism
  • Lysophospholipids / antagonists & inhibitors
  • Lysophospholipids / blood
  • Lysophospholipids / metabolism*
  • Molecular Targeted Therapy
  • Platelet Activation
  • Signal Transduction
  • Sphingosine / analogs & derivatives*
  • Sphingosine / antagonists & inhibitors
  • Sphingosine / blood
  • Sphingosine / metabolism
  • Thrombosis / blood
  • Thrombosis / metabolism

Substances

  • Anti-Inflammatory Agents
  • Lysophospholipids
  • sphingosine 1-phosphate
  • Sphingosine